News | July 2, 2013

West Expands NovaGuard™ Platform of Products for Safe and Effective Injectable Drug Delivery

The NovaGuard SA (Staked-needle Automatic) system, formerly called the B.Safe syringe system technology, is now part of the NovaGuard system technology platform of syringe safety systems that build on West’s expertise in safe drug administration and needlestick prevention features. The NovaGuard SA system technology has been introduced to provide a global solution for reducing the risk of needlestick injuries around staked-needle prefilled syringe systems. Prospective customers began evaluating NovaGuard SA last year, and West is expanding capacity to meet expected increases in market demand.

West works side-by-side with top pharmaceutical and biotechnology companies to design and manufacture drug packaging and delivery systems that bring injectable drugs from concept to the patient efficiently, reliably and safely. The NovaGuard products platform brings several of West’s leading drug delivery and needle safety technologies together under a unified brand aimed at enhancing the safety, convenience and effectiveness of drug administration, and will complement West’s broad packaging and delivery solutions for drugs packaged in a prefillable syringe.

“Every day, injectable drugs using West technologies are administered to improve the lives of millions of patients around the world,” said Graham Reynolds, Vice President, Marketing and Innovation, West Pharmaceutical Services. “It is essential that these drugs are delivered as safely as possible so patients and healthcare workers alike are not put at risk. With our NovaGuard family of dependable, easy-to-use safety systems, we are able to meet growing market demand for safe drug delivery solutions worldwide and work together with our customers to create a healthier world.”

“Accidental needlestick injuries are a major cause of exposure to serious diseases among healthcare workers, with more than one million needlestick injuries occurring each year,” said Ron Stoker, Executive Director, International Sharps Injury Prevention Society. “We believe that a significant number of needlestick injuries can be prevented by adopting safety-engineered products and services. Innovative technologies such as West’s NovaGuard safety systems are vital to reducing the risk of life-threatening needlestick injuries and play a key role in keeping both healthcare workers and patients safe.”  

West’s most established safety product is the éris™ system, also used for staked-needle prefilled syringes. Over 1.3 billion éris systems have been used to date to help protect healthcare workers, patients and caregivers from the risk of a needlestick injury.

The range of solutions also includes NovaGuard LP (Luer-lock Passive), a passive safety system for Luer Lock syringes that features a plastic shield that surrounds the needle before injection, leaving only the needle tip exposed for injection site orientation. West has previously received 510k clearance for the NovaGuard LP system.

West has built a robust portfolio of technologies within the drug delivery market and is developing additional prefilled syringe safety systems.

About West
West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliability and safety of their products. Every day, West is leading the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched and growing knowledge base of relevant pharmaceutical product testing, development and packaging. Based in Exton, Pa., West supports its customers from sales, manufacturing, customer service and research and development facilities in North and South America, Europe, Asia and Australia. Established in 1923, West’s 2012 sales were $1.3 billion.

West Pharmaceutical Services, Inc.